Icon PublicCompany Share Price (NASDAQ: ICLR)

$174.34

▲

2.58

(1.5%)

Last updated on August 28, 2025 at 1:29 am IST

$₹

Check the interactive Icon PublicCompany Stock chart to analyse performance

Icon PublicCompany stock performance

as on August 28, 2025 at 1:29 am IST

Today's Low:$170.45
Today's High:$174.61
$174.34
2.23%
Downside
Day's Volatility :2.38%
Upside
0.15%
52 Weeks Low:$125.10
52 Weeks High:$328.04
$174.34
28.24%
Downside
52 Weeks Volatility :61.86%
Upside
46.85%

Icon PublicCompany Stock Returns

Period	Icon Public Limited Company	Sector (Health Care)	Index (Russel 2000)
3 Months	31.28%	4.2%	0.0%
6 Months	-9.26%	-8.0%	0.0%
1 Year	-46.35%	-12.0%	0.0%
3 Years	-17.76%	7.7%	-6.9%

Icon Public Limited Company Key Stats

Check Icon PublicCompany key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$171.76
Open	$170.84
Today's High	$174.61
Today's Low	$170.45
Market Capitalization	$13.4B
Today's Volume	$361.6K
52 Week High	$328.04
52 Week Low	$125.1
Revenue TTM	$8.1B
EBITDA	$1.6B
Earnings Per Share (EPS)	$9.71
PE Ratio	17.69
Profit Margin	9.82%
Quarterly Earnings Growth YOY	0.31%
Return On Equity TTM	8.3%

Stock Returns calculator for Icon PublicCompany Stock including INR - Dollar returns

The Icon PublicCompany stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Icon PublicCompany investment value today

Current value as on today

₹58,162

Returns

₹41,838

(-41.84%)

Returns from Icon PublicCompany Stock

₹46,523 (-46.52%)

Dollar Returns*

₹4,685 (+4.68%)

Indian investors sentiment towards Icon PublicCompany Stock

-44%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Icon PublicCompany Stock from India on INDmoney has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Icon Public Limited Company

Name
Holdings %
Name
Holdings %
Artisan Partners Limited Partnership
9.24%
Massachusetts Financial Services Company
4.82%
Wellington Management Company LLP
4.71%
Ninety One UK Limited
3.85%
Amvescap Plc.
3.84%
D. E. Shaw & Co LP
3.13%

Analyst Recommendation on Icon PublicCompany Stock

Rating

Trend

Buy

86%Buy

13%Hold

0%Sell

Based on 23 Wall street analysts offering stock ratings for Icon PublicCompany(by analysts ranked 0 to 5 stars)

Icon PublicCompany Share Price Target

What analysts predicted

Upside of 24.35%

Target:

$216.80

Current:

$174.34

Icon PublicCompany share price target is $216.80, a slight Upside of 24.35% compared to current price of $174.34 as per analysts' prediction.

Icon PublicCompany Stock Insights

Price Movement
In the last 7 days, ICLR stock has moved down by -2.1%
Increasing Revenue
Revenue is up for the last 2 quarters, 2.00B → 2.01B (in $), with an average increase of 0.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 154.15M → 182.97M (in $), with an average increase of 15.8% per quarter
ICLR vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 33.3% return, outperforming this stock by 79.7%
ICLR vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 83.4% return, outperforming this stock by 102.8%
Price to Sales
ForICLR every $1 of sales, investors are willing to pay $1.7, whereas for Idexx Laboratories, Inc., the investors are paying $12.9 for every $1 of sales.

Icon Public Limited Company Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$2.8B	↑ 8.09%
Net Income	$374.0M	↑ 15.85%
Net Profit Margin	13.33%	↑ 0.89%

	FY20	Y/Y Change
Revenue	$2.8B	↓ 0.3%
Net Income	$327.8M	↓ 12.35%
Net Profit Margin	11.72%	↓ 1.61%

	FY21	Y/Y Change
Revenue	$5.5B	↑ 95.93%
Net Income	$153.2M	↓ 53.27%
Net Profit Margin	2.79%	↓ 8.93%

	FY22	Y/Y Change
Revenue	$7.7B	↑ 41.24%
Net Income	$505.3M	↑ 229.87%
Net Profit Margin	6.53%	↑ 3.74%

	FY23	Y/Y Change
Revenue	$8.1B	↑ 4.89%
Net Income	$612.3M	↑ 21.18%
Net Profit Margin	7.54%	↑ 1.01%

	FY24	Y/Y Change
Revenue	$8.3B	↑ 1.99%
Net Income	$791.5M	↑ 29.26%
Net Profit Margin	9.56%	↑ 2.02%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$2.1B	↑ 1.17%
Net Income	$187.4M	↓ 13.39%
Net Profit Margin	8.97%	↓ 1.5%

	Q2 FY24	Q/Q Change
Revenue	$2.1B	↑ 1.42%
Net Income	$146.9M	↓ 21.62%
Net Profit Margin	6.93%	↓ 2.04%

	Q3 FY24	Q/Q Change
Revenue	$2.0B	↓ 4.25%
Net Income	$197.1M	↑ 34.18%
Net Profit Margin	9.71%	↑ 2.78%

	Q4 FY24	Q/Q Change
Revenue	$2.0B	↑ 0.55%
Net Income	$260.0M	↑ 31.89%
Net Profit Margin	12.74%	↑ 3.03%

	Q1 FY25	Q/Q Change
Revenue	$2.0B	↓ 1.95%
Net Income	$154.2M	↓ 40.71%
Net Profit Margin	7.7%	↓ 5.04%

	Q2 FY25	Q/Q Change
Revenue	$2.0B	↑ 0.8%
Net Income	$183.0M	↑ 18.7%
Net Profit Margin	9.07%	↑ 1.37%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$831.7M	↑ 8.09%

	FY20	Y/Y Change
Profit	$808.0M	↓ 2.85%

	FY21	Y/Y Change
Profit	$1.5B	↑ 86.65%

	FY22	Y/Y Change
Profit	$2.2B	↑ 46.82%

	FY23	Y/Y Change
Profit	$2.4B	↑ 8.39%

	FY24	Y/Y Change
Profit	$2.4B	↑ 1.51%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$469.8M	↓ 0.2%

	Q2 FY24	Q/Q Change
Profit	$476.9M	↑ 1.51%

	Q3 FY24	Q/Q Change
Profit	$591.4M	↑ 24.01%

	Q4 FY24	Q/Q Change
Profit	$599.4M	↑ 1.34%

	Q1 FY25	Q/Q Change
Profit	$558.7M	↓ 6.79%

	Q2 FY25	Q/Q Change
Profit	$463.9M	↓ 16.96%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$412.5M	↑ 56.26%
Investing Cash Flow	$-162.0M	↑ 334.44%
Financing Cash Flow	$-125.4M	↑ 15.69%

	FY20	Y/Y Change
Operating Cash Flow	$594.7M	↑ 44.16%
Investing Cash Flow	$-46.6M	↓ 71.25%
Financing Cash Flow	$-235.0M	↑ 87.41%

	FY21	Y/Y Change
Operating Cash Flow	$829.1M	↑ 39.42%
Investing Cash Flow	$-6.0B	↑ 12834.2%
Financing Cash Flow	$5.1B	↓ 2276.28%

	FY22	Y/Y Change
Operating Cash Flow	$563.3M	↓ 32.06%
Investing Cash Flow	$-145.9M	↓ 97.58%
Financing Cash Flow	$-864.2M	↓ 116.9%

	FY23	Y/Y Change
Operating Cash Flow	$1.2B	↑ 106.11%
Investing Cash Flow	$-226.7M	↑ 55.38%
Financing Cash Flow	$-844.0M	↓ 2.33%

	FY24	Y/Y Change
Operating Cash Flow	$1.3B	↑ 10.82%
Investing Cash Flow	$-266.8M	↑ 17.71%
Financing Cash Flow	$-837.2M	↓ 0.81%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$327.1M	↓ 23.79%
Investing Cash Flow	$-39.4M	↓ 67.36%
Financing Cash Flow	$-263.7M	↑ 6.7%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$216.4M	↓ 33.84%
Investing Cash Flow	$-33.9M	↓ 13.87%
Financing Cash Flow	$-70.4M	↓ 73.3%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$402.7M	↑ 86.07%
Investing Cash Flow	$-124.3M	↑ 266.73%
Financing Cash Flow	$-97.8M	↑ 38.87%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$338.3M	↓ 15.98%
Investing Cash Flow	$-68.9M	↓ 44.6%
Financing Cash Flow	$-404.0M	↑ 313.14%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$268.2M	↓ 20.71%
Investing Cash Flow	$-37.3M	↓ 45.88%
Financing Cash Flow	$-252.8M	↓ 37.41%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$162.2M	↓ 39.53%
Investing Cash Flow	$-41.1M	↑ 10.3%
Financing Cash Flow	$-275.5M	↑ 8.96%

Icon PublicCompany Technicals Summary

Sell

Neutral

Buy

Icon PublicCompany is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Icon Public Limited Company Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Icon Public Limited Company	-7.09%	-9.26%	-46.35%	-17.76%	-7.69%
Agilent Technologies Inc.	-1.05%	-6.92%	-16.14%	-7.67%	17.8%
Idexx Laboratories, Inc.	13.27%	45.49%	33.27%	83.83%	64.08%
Thermo Fisher Scientific, Inc.	0.75%	-6.62%	-20.31%	-12.23%	13.9%
Danaher Corp.	1.65%	0.28%	-22.46%	-25.44%	-0.09%
Iqvia Holdings Inc.	-5.01%	0.72%	-24.12%	-13.91%	14.72%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Icon Public Limited Company	17.69	17.69	1.27	13.29	0.08	0.04	NA	122.86
Agilent Technologies Inc.	29.14	29.14	1.75	5.58	0.19	0.08	0.01	21.61
Idexx Laboratories, Inc.	53.4	53.4	4.83	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.37	28.37	2.04	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	44.2	44.2	2.12	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.21	27.21	1.08	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Icon Public Limited Company	Buy	$13.4B	-7.69%	17.69	9.82%
Agilent Technologies Inc.	Buy	$33.6B	17.8%	29.14	17.59%
Idexx Laboratories, Inc.	Buy	$51.3B	64.08%	53.4	24.41%
Thermo Fisher Scientific, Inc.	Buy	$185.3B	13.9%	28.37	15.24%
Danaher Corp.	Buy	$148.7B	-0.09%	44.2	14.21%
Iqvia Holdings Inc.	Buy	$31.9B	14.72%	27.21	7.88%

About Icon Public Limited Company

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

Organization	Icon PublicCompany
Employees	39900
CEO	Dr. Steven A. Cutler MBA, Ph.D.
Industry	Health Technology

Key Management of Icon Public Limited Company

Name	Title
Dr. Steven A. Cutler MBA, Ph.D.	CEO & Director
Dr. John Climax Ph.D.	Founder & Independent Non-Executive Director
Mr. Nigel Clerkin A.C.A.	Chief Financial Officer
Mr. Barry Balfe	Chief Operating Officer
Mr. Thomas N. O'Leary	Chief Information Officer
Mr. Diarmaid Cunningham	Chief Administrative Officer, General Counsel & Company Secretary
Ms. Niamh Murphy	Director of Corporate Communications
Mr. David Green	Vice President of Marketing
Mr. Joe Cronin	Chief Human Resources Officer
Mr. Simon Holmes	President of Corporate Investments & Partnerships

Important FAQs about investing in ICLR Stock from India :

What is Icon PublicCompany share price today?

Icon PublicCompany share price today is $174.34 as on August 28, 2025 at 1:29 am IST at the close of the market. Icon PublicCompany share today touched a day high of $174.61 and a low of $170.45.

What is the 52 week high and 52 week low for Icon PublicCompany share?

Icon PublicCompany share touched a 52 week high of $328.04 and a 52 week low of $125.10. Icon PublicCompany stock price today i.e. August 28, 2025 at 1:29 am IST is closed at $174.34, lower by 46.85% versus the 52 week high.

How to invest in Icon PublicCompany Stock (ICLR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Icon PublicCompany on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Icon PublicCompany Shares that will get you 0.0086 shares as per Icon PublicCompany share price of $174.34 per share as on August 28, 2025 at 1:29 am IST.

What is the minimum amount required to buy Icon PublicCompany Stock (ICLR) from India?

Indian investors can start investing in Icon PublicCompany (ICLR) shares with as little as ₹87.86 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Icon PublicCompany stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Icon PublicCompany share’s latest price of $174.34 as on August 28, 2025 at 1:29 am IST, you will get 0.0574 shares of Icon PublicCompany. Learn more about fractional shares .

What are the returns that Icon PublicCompany has given to Indian investors in the last 5 years?

Icon PublicCompany stock has given -7.69% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?